Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Y Bowers

Showing results (41-50 of 155) with videos related to

Pageof 16
Sort By:
Biochemical and Biophysical Research Communications|February 14, 1979
A new category of ovulation inhibitors: linear LH-RH analogues having more than ten residuesT Wasiak, J Humphries, K Folkers, et al.
The Journal of Clinical Endocrinology and Metabolism|April 29, 1998
Pharmacokinetics and pharmacodynamics of growth hormone-releasing peptide-2: a phase I study in childrenC Pihoker, G L Kearns, D French, et al.
Biochemical and Biophysical Research Communications|November 27, 1974
Studies of inhibition of the luteinizing hormone-releasing hormone by an irreversible inhibitor at the receptor siteC Y Bowers, Y P Wan, J Humphries, et al.
Journal of Medicinal Chemistry|January 1, 1972
Synthesis of di- and tripeptides and assay in vivo for activity in the thyrotropin releasing hormone and the luteinizing releasing hormone systemsH Sievertsson, J K Chang, K Folkers, et al.
Biochemical and Biophysical Research Communications|September 23, 1977
On the importance of position one of ovulation inhibitors, as based on studies on [D-Phe2, Pro3, D-Phe6]-LHRHJ Humphries, Y P Wan, K Folkers, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1986
Decapeptides as effective agonists from L-amino acids biologically equivalent to the luteinizing hormone-releasing hormoneK Folkers, C Y Bowers, P F Tang, et al.
Novartis Foundation Symposium|February 22, 2002
Mechanisms of conjoint failure of the somatotropic and gonadal axes in ageing menJ D Veldhuis, A Iranmanesh, T Mulligan, et al.
Biology of Reproduction|August 1, 1980
Effect of [D-Phe2, Pro3, D-Phe6]-luteinizing hormone releasing hormone, an antagonist, on preovulatory gonadotropin secretion in the rhesus monkeyJ W Wilks, K Folkers, J Humphries, et al.
Journal of Medicinal Chemistry|February 1, 1976
Synthesis and some biological activities of the tyrosine-8 analog of substance PG H Fisher, K Folkers, B Pernow, et al.
Biochemical and Biophysical Research Communications|October 4, 1976
Presence of proline in position 3 for potent inhibition of the activity of the luteinizing hormone releasing hormone and of ovulationJ Humphries, Y P Wan, K Folkers, et al.
Pageof 16

Showing results (41-50 of 155) with videos related to

Sort By:
Pageof 16
Biochemical and Biophysical Research Communications|February 14, 1979
A new category of ovulation inhibitors: linear LH-RH analogues having more than ten residuesT Wasiak, J Humphries, K Folkers, et al.
The Journal of Clinical Endocrinology and Metabolism|April 29, 1998
Pharmacokinetics and pharmacodynamics of growth hormone-releasing peptide-2: a phase I study in childrenC Pihoker, G L Kearns, D French, et al.
Biochemical and Biophysical Research Communications|November 27, 1974
Studies of inhibition of the luteinizing hormone-releasing hormone by an irreversible inhibitor at the receptor siteC Y Bowers, Y P Wan, J Humphries, et al.
Journal of Medicinal Chemistry|January 1, 1972
Synthesis of di- and tripeptides and assay in vivo for activity in the thyrotropin releasing hormone and the luteinizing releasing hormone systemsH Sievertsson, J K Chang, K Folkers, et al.
Biochemical and Biophysical Research Communications|September 23, 1977
On the importance of position one of ovulation inhibitors, as based on studies on [D-Phe2, Pro3, D-Phe6]-LHRHJ Humphries, Y P Wan, K Folkers, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1986
Decapeptides as effective agonists from L-amino acids biologically equivalent to the luteinizing hormone-releasing hormoneK Folkers, C Y Bowers, P F Tang, et al.
Novartis Foundation Symposium|February 22, 2002
Mechanisms of conjoint failure of the somatotropic and gonadal axes in ageing menJ D Veldhuis, A Iranmanesh, T Mulligan, et al.
Biology of Reproduction|August 1, 1980
Effect of [D-Phe2, Pro3, D-Phe6]-luteinizing hormone releasing hormone, an antagonist, on preovulatory gonadotropin secretion in the rhesus monkeyJ W Wilks, K Folkers, J Humphries, et al.
Journal of Medicinal Chemistry|February 1, 1976
Synthesis and some biological activities of the tyrosine-8 analog of substance PG H Fisher, K Folkers, B Pernow, et al.
Biochemical and Biophysical Research Communications|October 4, 1976
Presence of proline in position 3 for potent inhibition of the activity of the luteinizing hormone releasing hormone and of ovulationJ Humphries, Y P Wan, K Folkers, et al.
Pageof 16